Personal tools

MCL coexpression mm9:2905: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000468!8.90e-07!333
|ontology_enrichment_uberon=UBERON:0000468!8.90e-07!333
|tfbs_overrepresentation_for_novel_motifs=1.77936,0.193418,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,1.23467,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,0.578045,0.448066,0.328717,0.679146,0.275782,0.932027,0.585919,0.731217,0.963352,0.437236,0.841386,0.64294,0.380786,0.825437,1.24901,0.575271,1.05917,0.608816,2.02463,1.38481,0.902078,0.536514,3.19233,0.582863,0.831295,0.261619,0.610669,0.922882,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,1.41919,1.44925,1.07031,1.03818,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,3.89074,0.195254,0.99201,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,1.31639,0.509215,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,0.609576,0.805461,1.14346,1.37508,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,2.65814,3.74474,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,3.36183
}}
}}

Revision as of 22:07, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr14:35315849..35315901,-p2@Bmpr1a
Mm9::chr8:131209774..131209811,+p3@Itgb1
Mm9::chr8:131209812..131209823,+p4@Itgb1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0007507heart development0.00314103617670155
GO:0008284positive regulation of cell proliferation0.00314103617670155
GO:0042684cardioblast cell fate commitment0.00314103617670155
GO:0042685cardioblast cell fate specification0.00314103617670155
GO:0048382mesendoderm development0.00314103617670155
GO:0001880Mullerian duct regression0.00314103617670155
GO:0042127regulation of cell proliferation0.00628172816797938
GO:0010002cardioblast differentiation0.00628172816797938
GO:0060033anatomical structure regression0.00628172816797938
GO:0009950dorsal/ventral axis specification0.00753786729032103
GO:0008283cell proliferation0.00999617726056794
GO:0045214sarcomere organization0.0134564208330796
GO:0004675transmembrane receptor protein serine/threonine kinase activity0.0134564208330796
GO:0005024transforming growth factor beta receptor activity0.0134564208330796
GO:0031594neuromuscular junction0.0134564208330796
GO:0030239myofibril assembly0.0134564208330796
GO:0055002striated muscle cell development0.0134564208330796
GO:0048522positive regulation of cellular process0.0134564208330796
GO:0050679positive regulation of epithelial cell proliferation0.0134564208330796
GO:0055001muscle cell development0.0134564208330796
GO:0035051cardiac cell differentiation0.0134564208330796
GO:0009798axis specification0.0139237070595951
GO:0007492endoderm development0.0139237070595951
GO:0048518positive regulation of biological process0.0141257569973187
GO:0031032actomyosin structure organization and biogenesis0.0141257569973187
GO:0048628myoblast maturation0.0141257569973187
GO:0048627myoblast development0.0141257569973187
GO:0005178integrin binding0.0141257569973187
GO:0035137hindlimb morphogenesis0.0141257569973187
GO:0001708cell fate specification0.0141257569973187
GO:0050678regulation of epithelial cell proliferation0.0141257569973187
GO:0000082G1/S transition of mitotic cell cycle0.0141257569973187
GO:0046661male sex differentiation0.0154086494961967
GO:0042383sarcolemma0.0155089344533936
GO:0051146striated muscle cell differentiation0.01560345934
GO:0050673epithelial cell proliferation0.0162153497277896
GO:0008305integrin complex0.0173024896210547
GO:0045445myoblast differentiation0.0178371922030721
GO:0051325interphase0.0192962050831568
GO:0051329interphase of mitotic cell cycle0.0192962050831568
GO:0009953dorsal/ventral pattern formation0.0197428032994193
GO:0004702receptor signaling protein serine/threonine kinase activity0.020048920647292
GO:0048513organ development0.020048920647292
GO:0051216cartilage development0.020048920647292
GO:0007498mesoderm development0.020048920647292
GO:0032403protein complex binding0.020048920647292
GO:0019717synaptosome0.0208220025003276
GO:0042692muscle cell differentiation0.0225101491194736
GO:0007160cell-matrix adhesion0.0225101491194736
GO:0048741skeletal muscle fiber development0.0225101491194736
GO:0030324lung development0.0225101491194736
GO:0048747muscle fiber development0.0225101491194736
GO:0030323respiratory tube development0.0225101491194736
GO:0031589cell-substrate adhesion0.0225101491194736
GO:0043235receptor complex0.0225101491194736
GO:0019199transmembrane receptor protein kinase activity0.0225101491194736
GO:0007548sex differentiation0.0225101491194736
GO:0048731system development0.0225101491194736
GO:0048469cell maturation0.0225101491194736
GO:0035107appendage morphogenesis0.0225101491194736
GO:0035108limb morphogenesis0.0225101491194736
GO:0048869cellular developmental process0.0225101491194736
GO:0030154cell differentiation0.0225101491194736
GO:0060173limb development0.0225101491194736
GO:0048736appendage development0.0225101491194736
GO:0007178transmembrane receptor protein serine/threonine kinase signaling pathway0.0225101491194736
GO:0045596negative regulation of cell differentiation0.0234347923769146
GO:0005057receptor signaling protein activity0.0234347923769146
GO:0003006reproductive developmental process0.0234347923769146
GO:0007229integrin-mediated signaling pathway0.0240954568246319
GO:0021700developmental maturation0.0240954568246319
GO:0009952anterior/posterior pattern formation0.0244627432461561
GO:0007519skeletal muscle development0.0244627432461561
GO:0048856anatomical structure development0.0249770199198955
GO:0045165cell fate commitment0.0249770199198955
GO:0007398ectoderm development0.0249770199198955
GO:0051093negative regulation of developmental process0.0253828078295289
GO:0001701in utero embryonic development0.0286596186228907
GO:0014706striated muscle development0.0290078124494747
GO:0007275multicellular organismal development0.029292524320212
GO:0030145manganese ion binding0.0299091014344784
GO:0003002regionalization0.033650165201287
GO:0045595regulation of cell differentiation0.0344065819266945
GO:0030036actin cytoskeleton organization and biogenesis0.0344065819266945
GO:0030029actin filament-based process0.0358386395598984
GO:0007517muscle development0.0358386395598984
GO:0007166cell surface receptor linked signal transduction0.0358386395598984
GO:0001501skeletal development0.0383600521512519
GO:0035295tube development0.0423296095286837
GO:0022414reproductive process0.0428946476526525
GO:0004872receptor activity0.0435784814301501
GO:0032502developmental process0.0441059329296329
GO:0043009chordate embryonic development0.044165931537471
GO:0009792embryonic development ending in birth or egg hatching0.044165931537471
GO:0000278mitotic cell cycle0.044165931537471
GO:0007389pattern specification process0.0456444403706497
GO:0004871signal transducer activity0.0467989271816792
GO:0060089molecular transducer activity0.0467989271816792
GO:0050793regulation of developmental process0.0483932215224717
GO:0007167enzyme linked receptor protein signaling pathway0.0497670129224057
GO:0022403cell cycle phase0.0498889685485099
GO:0050794regulation of cellular process0.0498889685485099



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
multi-cellular organism8.90e-07333


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}